The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome

Anesthesia and Analgesia

Volumn 93, Issue 2, 2001, Pages 400-404

  Dhonneur, Gilles ^a   Cerf, Charles ^a   Lagneau, Franck ^b   Mantz, Jean ^c   Gillotin, Catherine ^d   Duvaldestin, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d Laboratoire Glaxo Wellcome   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM;

ADULT; ARTICLE; BLOOD SAMPLING; BREATHING MECHANICS; CLINICAL ARTICLE; ELECTIVE SURGERY; FEMALE; HUMAN; LUNG COMPLIANCE; MALE; NEUROMUSCULAR BLOCKING; ORBICULARIS OCULI MUSCLE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TISSUE OXYGENATION;

EID: 0034928481     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200108000-00033     Document Type: Article

References (28)

1. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome
2. The effect of mechanical ventilation on oxygen consumption in critically ill patients
3. Comparison of train-of-four and best clinical assessment during continuous paralysis
4. Pancuronium-induced prolonged neuromuscular blockade
5. Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans
6. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles
7. The lack of histamine release with cisatracurium: A double-blind comparison with vecuronium
8. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia
9. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients
10. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients
11. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia
12. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients
13. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients
14. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit
15. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients
16. Do the pharmacokinetics of vecuronium change during prolonged administration in critically ill patients?
17. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure
18. Muscle relaxants in renal disease
19. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis
20. Importance of the organ-independent elimination of cisatracurium
21. Persistent paralysis in critically ill patients after long-term administration of vecuronium
22. Cardiovascular and neurological effects of laudanosine
23. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature
24. Double-blind randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular blocking agents
25. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents
26. Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade
27. Neuromuscular blockade in the intensive care unit: More than we bargained for
28. Myopathy in critically ill patients